Teva Pharmaceutical Industries, Ltd.: all 671 studies
Page 4 of 7. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- Azithromycin 600 Mg Tablets, FedCompletedNCT00834132Phase 1Results posted
- Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting ConditionsCompletedNCT00834067Phase 1Results posted
- Zolpidem Tartrate 10 mg Tablets Under Non-Fasting ConditionsCompletedNCT00833937Phase 1Results posted
- Terbinafine HCl 250 mg Tablet Formulations Under Non-Fasting ConditionsCompletedNCT00833664Phase 1Results posted
- Terbinafine HCl 250 mg Tablet Under Fasting ConditionsCompletedNCT00833586Phase 1Results posted
- Zolpidem Tartrate 10 mg Tablets Under Fasting ConditionsCompletedNCT00833521Phase 1Results posted
- A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting ConditionsCompletedNCT00830336Phase 1Results posted
- Pravastatin Sodium 80 mg Tablets Under Fasting ConditionsCompletedNCT00830258Phase 1Results posted
- The Relative Bioavailability Study of Two Ropinirole 0.25 mg Tablets Under Fed ConditionsCompletedNCT00830219Phase 1Results posted
- A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting ConditionsCompletedNCT00830206Phase 1Results posted
- Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Non-fasting ConditionsCompletedNCT00830024Phase 1Results posted
- Zaleplon 10mg Capsules Under Fasting ConditionsCompletedNCT00829998Phase 1Results posted
- Zaleplon 10 mg Capsules Under Non-Fasting ConditionsCompletedNCT00829868Phase 1Results posted
- Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed ConditionsCompletedNCT00829790Phase 1Results posted
- Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fasting ConditionsCompletedNCT00829764Phase 1Results posted
- Dexmethylphenidate Hydrochloride Tablets Under Fasting ConditionsCompletedNCT00829712Phase 1Results posted
- Dexmethylphenidate Hydrochloride Tablets Under Non-Fasting ConditionsCompletedNCT00829673Phase 1Results posted
- Ramipril 10 mg Capsule in Healthy Subjects Under Fed ConditionsCompletedNCT00829530Phase 1Results posted
- Ropinirole 0.25 mg Tablets Under Fasting ConditionsCompletedNCT00829504Phase 1Results posted
- Ramipril 10 mg Capsule in Healthy Subjects Under Fasting ConditionsCompletedNCT00829452Phase 1Results posted
- Alprazolam Extended-Release 3mg Tablets Bioequivalence Study Under Fasting ConditionsCompletedNCT00829426Phase 1Results posted
- Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting ConditionsCompletedNCT00829309Phase 1Results posted
- Ramipril 10 mg Capsule in Healthy Subjects Under Fasting ConditionsCompletedNCT00828321Phase 1Results posted
- Safety and Efficacy of Armodafinil for Fatigue Associated With Taxanes Alone or in Combination With Other AgentsTerminatedNCT00825227Phase 2Results posted
- Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for Breakthrough Pain in Patients With Chronic PainCompletedNCT00813488Phase 3Results posted
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over Twelve MonthsCompletedNCT00806546Phase 3Results posted
- An Open-Label Study to Evaluate the Safety of NP101 in the Treatment of Acute Migraine Over 12 MonthsCompletedNCT00792103Phase 3Results posted
- A Multicenter Study to Evaluate the Efficacy of a 91-Day Extended Cycle Oral Contraceptive for Menstrually-Related Migraine HeadachesCompletedNCT00781456Phase 2Results posted
- Emergency Contraception Actual Use StudyCompletedNCT00777556Phase 3Results posted
- Study to Evaluate the Efficacy and Safety of Armodafinil as Adjunctive Therapy in Adults With SchizophreniaCompletedNCT00772005Phase 2Results posted
- Comparison of One Morphine Sulfate Sustained-Release 200 mg Capsule With Two 100 mg KADIAN Capsules on ApplesauceCompletedNCT00759954Phase 1Results posted
- Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fed ConditionsCompletedNCT00759915Phase 1Results posted
- Comparison of Two KADIAN 10 mg Capsules to a KADIAN 20 mg Capsule Under Fasted ConditionsCompletedNCT00759902Phase 1Results posted
- Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fasting ConditionsCompletedNCT00759759Phase 1Results posted
- Comparison of One Morphine Sulfate Sustained-Release 200mg Capsule With Two 100 mg KADIAN Capsules Under Fed ConditionsCompletedNCT00759356Phase 1Results posted
- Study of the Effect of Armodafinil Treatment in Healthy Subjects With Excessive Sleepiness Associated With Jet Lag DisorderCompletedNCT00758498Phase 3Results posted
- An Extension Study of LAQ/5062 Exploring the Long Term Safety, Tolerability and Clinical Effect Parameters During the DiseaseTerminatedNCT00745615Phase 2Results posted
- The Efficacy and Tolerability of NP101 Patch in the Treatment of Acute MigraineCompletedNCT00724815Phase 3Results posted
- A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's DiseaseCompletedNCT00724048Phase 2Results posted
- Combination Therapy With MYOCET® (Doxorubicin HCL Liposome for Injection) in Participants With HER2-Positive Breast CancerCompletedNCT00712881Phase 2Results posted
- Study to Evaluate Armodafinil Treatment in Improving Prefrontal Cortical Activation and Working Memory PerformanceCompletedNCT00711516Phase 4Results posted
- Evaluate Early Glatiramer Acetate Treatment in Delaying Conversion to Clinically Definite Multiple Sclerosis of Subjects Presenting With Clinically Isolated SyndromeCompletedNCT00666224Phase 3Results posted
- A Study of Treatment With Pridopidine (ACR16) in Participants With Huntington's DiseaseCompletedNCT00665223Phase 3Results posted
- Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic EsophagitisCompletedNCT00635089Phase 3Results posted
- BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)CompletedNCT00605215Phase 3Results posted
- Study to Evaluate the Effects of Synthetic Conjugated Estrogens, B (SCE-B) on Nocturnal Vasomotor Symptoms in Postmenopausal WomenCompletedNCT00592839Phase 4Results posted
- Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled AsthmaCompletedNCT00587288Phase 2Results posted
- Albuterol HFA MDI in Pediatric Participants With AsthmaCompletedNCT00577655Phase 3Results posted
- A Study to Evaluate Hormone Patterns and Ovarian Follicular Activity With DR-1021CompletedNCT00544882Phase 3Results posted
- Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 YearsCompletedNCT00538434Phase 2/3Results posted
- Comparison of Single-Dose Efficacy of an Albuterol Breath-Actuated Inhaler (Albuterol-HFA-BAI) Versus an Albuterol Metered-Dose Inhaler (Albuterol-HFA-MDI) in Participants With AsthmaCompletedNCT00530062Phase 4Results posted
- Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and DepressionCompletedNCT00518986Phase 4Results posted
- Cytarabine in Combination With Arsenic Trioxide vs. Cytarabine Alone in Elderly Patients With Acute Myeloid LeukemiaTerminatedNCT00513305Phase 3Results posted
- Safety and Efficacy of Orally Administered Laquinimod Versus Placebo for Treatment of Relapsing Remitting Multiple Sclerosis (RRMS)CompletedNCT00509145Phase 3Results posted
- Efficacy and Safety of Armodafinil as Adjunctive Therapy in Schizophrenic Adults With Cognitive DeficitsCompletedNCT00487942Phase 2Results posted
- Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I DisorderCompletedNCT00481195Phase 2Results posted
- Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through PainCompletedNCT00463047Phase 3Results posted
- Open Label Study of Subcutaneous Homoharringtonine (Omacetaxine Mepesuccinate) in Patients With Advanced CMLCompletedNCT00462943Phase 2Results posted
- A Study to Evaluate Bleeding Patterns With Three Different Doses of DR-1031 Compared to SeasonaleCompletedNCT00394771Phase 2Results posted
- Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough PainTerminatedNCT00387010Phase 3Results posted
- A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001CompletedNCT00382408Phase 3Results posted
- Homoharringtonine (Omacetaxine Mepesuccinate) in Treating Patients With Chronic Myeloid Leukemia (CML) With the T315I BCR-ABL Gene MutationCompletedNCT00375219Phase 2Results posted
- A Clinical Trial to Evaluate the Safety and Efficacy of DR-2041(Synthetic Conjugated Estrogens, A) for Treatment of Vulvovaginal AtrophyCompletedNCT00361569Phase 3Results posted
- Clinical Trial Comparing Treatment of Relapsing-Remitting Multiple Sclerosis (RR-MS) With Two Doses of Glatiramer Acetate (GA).CompletedNCT00337779Phase 3Results posted
- Clinical Trial of Glatiramer Acetate in Amyotrophic Lateral Sclerosis (ALS)CompletedNCT00326625Phase 2Results posted
- Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric AsthmaticsCompletedNCT00308685Phase 3Results posted
- A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's DiseaseCompletedNCT00256204Phase 3Results posted
- Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGILCompletedNCT00236080Phase 3Results posted
- Study to Assess Patient Reported Outcomes With Armodafinil Treatment for Excessive Sleepiness in Adults With Narcolepsy or Obstructive Sleep Apnea/Hypopnea SyndromeCompletedNCT00228566Phase 3Results posted
- Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive SleepinessCompletedNCT00228553Phase 3Results posted
- Assessment Study of Steroid Effect in Relapsing Multiple Sclerosis Subjects Treated With Glatiramer AcetateTerminatedNCT00203047Phase 4Results posted
- Glatiramer Acetate (Copaxone®) Study to Follow Participants From the First Original Study for Safety and EffectivenessCompletedNCT00203021Phase 4Results posted
- Open-label Study to Evaluate the Efficacy and Safety of an Extended-cycle, Low Dose Combination Oral ContraceptiveCompletedNCT00196326Phase 3Results posted
- A Study to Evaluate the Efficacy of Seasonique for the Treatment of Cyclic Pelvic PainCompletedNCT00196313Phase 2Results posted
- Homoharringtonine With Oral Gleevec in Chronic, Accelerated and Blast Phase Chronic Myeloid Leukemia (CML)TerminatedNCT00114959Phase 2Results posted
- Safety/Efficacy Study With Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Chronic SWSDCompletedNCT00080288Phase 3Results posted
- Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea (OSA/H) SyndromeCompletedNCT00079677Phase 3Results posted
- Safety and Efficacy Study of Armodafinil (CEP-10953) in the Treatment of Excessive Sleepiness Associated With NarcolepsyCompletedNCT00078377Phase 3Results posted
- Armodafinil (CEP-10953) in Treatment of Excessive Sleepiness Associated With Obstructive Sleep Apnea/Hypopnea Syndrome(OSAHS)CompletedNCT00078325Phase 3Results posted
- Armodafinil (CEP-10953) for Treatment of Narcolepsy, Obstructive Sleep Apnea/Hypopnea Syndrome, or Chronic Shift Work Sleep DisorderCompletedNCT00078312Phase 3Results posted
- A Study to Assess New Formulations of TEV-56286CompletedNCT06911567Phase 1
- A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac DiseaseActive, not recruitingNCT06807463Phase 2
- Study Comparing Tapinarof Cream 1% To VTAMA ® (Tapinarof Cream 1%) In the Treatment of Plaque PsoriasisCompletedNCT06742957Phase 3
- A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With AsthmaCompletedNCT06664619Phase 3
- Mass Balance Clinical Trial With TEV-56286CompletedNCT06627231Phase 1
- A Trial to Test if TEV-56286 is Effective for Treatment of Participants With Multiple System AtrophyActive, not recruitingNCT06568237Phase 2
- An Open-Label Trial to Assess the Comparative Bioavailability of TV-44749 to Oral Olanzapine in Participants With SchizophreniaCompletedNCT06315283Phase 1
- Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years OldCompletedNCT06290102Phase 1
- A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma ExacerbationsActive, not recruitingNCT06052267Phase 3
- A Study to Evaluate the Long-Term Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's DiseaseActive, not recruitingNCT05668013Phase 2
- A Study to Test if Fremanezumab Reduces Pain in Patients With Interstitial Cystitis-Bladder Pain SyndromeWithdrawnNCT04447729Phase 2
- A Study to Evaluate the Safety, Tolerability and Efficacy of Intravenous TAK-573 as Part of Combination Therapy in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)WithdrawnNCT04392648Phase 1
- An Open-Label, Single-Center Study to Evaluate the Exposure-Response Relationship Between the Plasma Drug Concentrations and the Change From Baseline in QTc at Steady State Following Once-daily Administration of CASSIPA® in Opioid Dependent Subjects.WithdrawnNCT04088266Phase 4
- Therapeutic Equivalence of Fluticasone Propionate Pressurized Metered Dose Inhaler, 110 mcg, to Flovent® HFA 110 mcgCompletedNCT03879837Phase 3
- Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"CompletedNCT03209479
- Cafedrin/Theodrenalin (Akrinor®) Versus Ephedrine for Treatment of Hypotension in the Peri-operative Phase in Inpatient SettingCompletedNCT02893241
- A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.CompletedNCT02809989
- A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 DiabetesWithdrawnNCT02769091Phase 2
- Safety, Pharmacokinetic, and Tolerability Study of Zecuity® in Adolescent Subjects With a History of Acute MigraineCompletedNCT02684409Phase 1
- A Double Blind Open Label Comparator Study to Compare Treatments in 4 to 11 Year Old Patients With AsthmaCompletedNCT02680561Phase 1
← Teva Pharmaceutical Industries, Ltd. overview and focus areas